mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for DPF2
Gene summary
Basic gene Info.Gene symbolDPF2
Gene nameD4, zinc and double PHD fingers family 2
SynonymsREQ|UBID4|ubi-d4
CytomapUCSC genome browser: 11q13
Type of geneprotein-coding
RefGenesNM_006268.4,
DescriptionBAF45DBRG1-associated factor 45Dapoptosis response zinc finger proteinprotein requiemrequiem, apoptosis response zinc fingerzinc finger protein ubi-d4
Modification date20141215
dbXrefs MIM : 601671
HGNC : HGNC
Ensembl : ENSG00000133884
HPRD : 03394
Vega : OTTHUMG00000165985
ProteinUniProt: Q92785
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_DPF2
BioGPS: 5977
PathwayNCI Pathway Interaction Database: DPF2
KEGG: DPF2
REACTOME: DPF2
Pathway Commons: DPF2
ContextiHOP: DPF2
ligand binding site mutation search in PubMed: DPF2
UCL Cancer Institute: DPF2
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for DPF2

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
H232H230YLUAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for DPF2
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
H232H230Y-0.48715525
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for DPF2 from PDB

Top
Differential gene expression and gene-gene network for DPF2
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of DPF2 and the right PPI network was created from samples without mutations in the LBS of DPF2. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for DPF2
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for DPF2
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of DPF2 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
ZNZINC(2+)3iufAH232


Top
Conservation information for LBS of DPF2
Multiple alignments for Q92785 in multiple species
LBSAA sequence# speciesSpecies
C211DKPYACD----2Homo sapiens, Mus musculus
C211DKPYACDNSYK1Gallus gallus
C214----ICGKRYK2Homo sapiens, Mus musculus
C214PPDRVCGKRYK1Gallus gallus
H227PGLSYHYAHSH3Homo sapiens, Gallus gallus, Mus musculus
H232HYAHSHLAEEE3Homo sapiens, Gallus gallus, Mus musculus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas